The underlying genomic variation of a large number of pathogenic viruses can give rise to drug resistant mutations resulting in treatment failure. Next generation sequencing (NGS) enables the identification of viral quasi-species and the quantification of minority variants in clinical samples; therefore, it can be of direct benefit by detecting drug resistant mutations and devising optimal treatment strategies for individual patients.
Viruses are intracellular parasites and most are characterised by a high replication rate within their host. During replication the polymerase proteins are prone to transcription errors or mutations, with RNA viruses having the highest mutation rates. New genomes containing mutations are continuously generated and selected on the basis of their fitness to infect and to replicate within the host's cells [1] . Average mutation rates of RNA viruses are about 10 −4 -10 −5 errors per nucleotide copied or, based on average genomic sizes, about one mutation per genome copied [2] . Moreover, recombination of genomic parts increases the evolution dynamics and the genomic divergence within viral populations. One such example is the Human Immunodeficiency Virus (HIV), where the recombination is considered faster than the mutation rate [3] . These and other features suggest that a viral population is actually made of an ensemble of related mutants that can be described as a quasi-species and on which the selective pressure influences all the viruses as a single unit.
Such high genomic variability allows the viral populations to survive challenges mounted by the host's immune system and by antiviral agents, hindering the effective treatment of patients and making it difficult to eradicate infections [4] . Next-Generation Sequencing (NGS) coupled with bioinformatics analyses enables the high-throughput detection of genomic variants and the classification of known and novel viral species overcoming the need for expensive culturing and/or labour-intensive Sanger sequencing techniques [5] .
Within the context of a clinical setting, NGS data can be applied on sequenced diagnostic samples to identify pathogens by assembling whole genomes and quantifying low-level drug resistance mutations below the 15-20% frequency sensitivity limit of the traditional Sanger sequencing technique [6] .
Computational pipelines that employ NGS data have been developed recently to discover new pathogens [7, 8] , to identify viral quasi-species [9, 10] and to detect genomic variants [11] [12] [13] [14] . However, in order to impact patient treatment pathways, it is necessary for pipelines to be capable of combining a number of characteristics at the same time. These are the ability to be pathogen agnostic, to assemble de novo whole genomes, to report minority variants, to be scalable for high-throughput analyses, customisable and portable to different software environments.
To this end a computational pipeline for analysing NGS data was developed that meets all of these above requirements. The input data are unprocessed paired-end reads from residual clinical diagnostic samples obtained under appropriate ethics permissions, while the output reports the consensus genome and all minority variants present in the viral quasi-species.
The pipeline is part of the ICONIC project, which uses viral genomic data to provide decision support towards the personalised treatment of patients; to guide hospital infection control responses; and to inform the surveillance and epidemiological responses to viral community outbreaks.
Methods

Pipeline Installation
The pipeline has been developed for analysing batches of sample paired-end reads on a High Performance Computing (HPC) cluster or on a server running the Son of Grid Engine scheduler (which must be installed separately). The software can be built either by the provided installation script or from a Dockerfile [https://www.docker.com/]. Both of these alternatives automatically: (1) download the pipeline dependencies, (2) configure the pipeline and (3) install it on the local appliance. Finally, the pipeline can be loaded as a bundle of Environment Modules [15] which can be used immediately. A pre-built binary version is also available as a docker image.
Read Analysis
The pipeline takes as input a batch of Illumina paired-end read FASTQ files generated from one or more samples, returning the consensus genome, minority variants and a set of statistics and QC metrics for each analysed sample and for the whole batch. It consists of a number of well-defined functional steps which allow the pipeline to be run from a particular starting point or to independently run a specific step. These functional steps can be optimised through a configuration file, which stores all the parameters used during the analysis. After parsing the input arguments, the pipeline initialises and sends an array job to the HPC cluster, which runs the analysis of each sample's reads in parallel to facilitate rapid analysis. Each job is composed of six distinct steps as shown in Figure 1 . (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) is run both before and after this filtering step to perform quality control checks and to spot potential sequencing biases.
The results are saved in each sample's output folder to allow subsequent inspection of read quality.
The second step generates contigs by de novo assembly of the filtered paired-end reads. In the current implementation, contigs are generated by the IVA de novo assembler [19] (version 1.0.0).
In the third step contigs are aligned with BLAST+[20] (version 2.2.30) against a local BLAST database of genomic sequences of the viral species specified as input, in order to identify the best match or closest reference. For segmented genomes (e.g. Influenza) this step identifies multiple best hits corresponding to each segment, thus allowing for potential reassortment.
The fourth step creates a draft genome from the assembled contigs. Using LASTZ [21] (1.07.73) these are aligned to the previously found closest reference sequence or segments.
Where contig alignments to the closest reference overlap, the draft sequence is taken from the contig with the highest read depth of coverage. Where contig alignments do not fully cover the coding sequence of the closest reference, gaps are filled with the missing sequence from the reference.
In the fifth step, an iterative approach is then used to generate the final consensus genome.
Firstly, filtered reads are mapped to the draft genome (using SMALT or BWA) from which a pileup file is generated with Samtools. The pileup file is then parsed at each genomic position to quantify sequence variants relative to the draft genome. This variants data is allowing the pipeline to analyse NGS data of any virus.
Ethics permissions
The ICONIC study has REC approval (13/LO/1303) received on 20th August 2013, IRAS project ID 131373. The favourable opinion applies to all NHS sites taking part in the study, while additional permissions have been obtained from the NHS/HSC R&D offices of all partner sites prior to the start of the study.
Results
The capability of the pipeline to build de novo genomes was assessed using publicly available read datasets and, as an example, the results on a set of Human Respiratory Syncytial Virus (RSV) reads are shown. The pipeline performances were also tested on a bigger clinical sample datasets consisting of 341 Influenza virus samples sequenced at the Wellcome Trust Sanger Institute on an Illumina MiSeq machine.
Comparison with publicly available RSV genomes
A test batch of 39 publicly available sequences with deposited reads was selected at random Therefore, our pipeline can build consistently full-size genomes and also contribute to the deposited public sequences by improving their genomic coverage.
Analysis of Influenza clinical samples
The database used as reference set for the Influenza analysis was created using the Human Influenza full genomes belonging to any serotype downloaded from the NCBI's Influenza Virus Resource (October 2015). The pipeline reported 169 genomes on a total of 342 (~50%) samples, while the rest did not contain enough viral reads to be de novo assembled into contigs. To overall assess the degree to which the consensus genomes covered the Influenza segments, these were aligned against a H1N1 sequence (strain: A/California/07/2009).
Although the Influenza segments are relatively short (around 2000 bases for the longest one), the pipeline was able to create either partial or full-length segments (an example is shown by the genome depth in Figure S1 and Figure S2 for segment 1 and 4 respectively).
The reads depth along the consensus genome qualitatively identified regions where the sequencing have been successful; Figure 2 illustrates one Influenza sample, showing that the number of aligned reads is higher at the ends of the segment than in the central region.
Moreover, the number of soft-clipped reads highlighted regions where the alignment to the consensus genome is more difficult. For each consensus genome it was possible to inspect the minority variants in a table through: (1) their type (substitution, insertion or deletion), (2) the variant frequency and (3) the ratio between the amount of forward and reverse reads. By plotting the distribution of each single mutation against the consensus sequence (as shown in Figure 3 ), it was possible to identify genomic regions with high variability. The Influenza virus is characterized by a relatively low mutation rate; therefore, the number of minority variants at each position is quite small compared to high mutation rate viral genomes as HIV (as displayed for the Influenza segment 1 in Figure S3 in the Supplementary Material). The length of each assembled segment depends on the number of filtered reads available for that particular region, which can be assessed from the distribution of the median read depth ( Figure S4 in the Supplementary Material). The segment coverage across the entire dataset is plotted in Figure S5 (Supplementary Material) through the distribution of the consensus genome coverage against its reference (Ns in the consensus genome are ignored); the median coverage was 100% for all segments and at least 50% for the first three segments in half of the dataset samples. The minority variant identified in the last step of the pipeline are aggregate from all the sample results and reported as well for each segment.
Performances
The analysis was performed using University College London's HPC cluster "Legion" on 124 dedicated Dell C6220 nodes, where each node can work as a 16 core Symmetric Multi-Processing device with 64 GB of RAM. Legion runs an operating system based on Red Hat Enterprise Linux 7 with the Son of Grid Engine batch scheduler.
When the RSV samples were analysed, the pipeline ran for an average of about 2 hours per sample, and for less than 10 hours when the whole dataset. The analysis of the Influenza lasted on average less than 5 hours per sample and below 12 hours for the whole dataset (apart from 5 samples, for which the analysis took around 20 hours due to an exceptional long mapping time to the decoy genome).
The longest steps were the read alignment to the decoy genome and the de novo assembly, which were responsible for most of the pipeline execution time and increases with the nucleotide variability of the reads. All the software, except the scripts that build the consensus genome and manage the flow of the data through the workflow, was run in multi-threading mode using all the cores available to decrease the computational time of the analysis.
The memory used through the analysis had an initial peak around 10 GB, while aligning the raw reads to the decoy genome, and it reached 2 GB during the de novo assembly step; otherwise, the average memory load is about 500 MB.
Finally, Docker images have a negligible impact on the performances[22] and this holds true especially for our pipeline, since it is contained in a single Docker image.
Portability
The pipeline can be installed either from a Dockerfile or by an installation script on a GNU/Linux system, or it can be ran directly as a docker image. The former installation method can be used on a dedicated single-user appliance, while the latter is better suited for environments shared among multiple users, hence addressing different set up needs.
Often Docker cannot be installed on academic clusters for security reasons, as the ability of running docker images is equivalent to having access to root privileges [Docker Security:
https://docs.docker.com/engine/articles/security/]. In these cases Environmental Modules are used to make sure all software dependencies are loaded with the correct version. This option was necessary to address the between-institutions portability.
The pipeline and its documentation can be downloaded or cloned from the GitHub repository at https://github.com/ICONIC-UCL/pipeline
Discussion
Motivated by the increasing potential to apply NGS on clinical viral samples as a method to improve the treatment of patients affected by viral diseases, a high-throughput computational pipeline was developed as part of the ICONIC project to assemble viral consensus genomes de novo and to detect minority variants in viral residual clinical samples.
As the pipeline accepts raw reads, it is possible to analyse sequencing data as soon as they are produced without the need of any pre-processing step. Moreover, the pipeline can analyse reads from any viral genome, segmented or not, for which at least one sequence, even partial, already exists. The consensus genome and the associated minority variants can be used to identify the dominant viral subtype and to quantify the variants occurring at specific positions and identifying the presence of drug resistance mutations. Furthermore, the possibility to run the pipeline in high-throughput mode is essential to facilitate analyses of potentially large numbers of patient samples during a seasonal outbreak of conditions of viral origin. Given the variety of information technologies employed within different clinical environments, the pipeline was designed to be easily ported to any cluster or server running a GNU/Linux system.
A set of publicly available RSV sample sequences were compared to the genomes generated by the pipeline presented here, starting from the deposited reads. Full genomes were generated in most of the samples, with half giving longer alignments to reference than those that are currently publicly available. In this way, the pipeline can successfully and It is not difficult to imagine that using current capability, a diagnostic report could be provided to a clinician within an actionable time window, as in our experience the end-toend process from patient sampling to genome assembly and clustering reporting takes approximately five days. One of the main strengths of the pipeline is that it can be utilised on sequencing data of any known virus, to generate de novo full length viral genomes, in which the sample quality is very variable and the virus subtype is unknown. These features empower our software to be eventually deployed in clinical settings as a decision support tool towards a personalised patient treatment and the improved information management of hospital infections. Legends for the supplementary material Table S1 . Sample identifiers from the Sequence Read Archive with the length of the associated deposited RSV genome and of the consensus sequence built by the ICONIC pipeline. 
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